UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934
                            (Amendment No. ________)*

                       Helius Medical Technologies, Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   42328V801
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                October 23, 2023
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)




Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_|  Rule 13d-1(b)
|X|  Rule 13d-1(c)
|_|  Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).













--------------------------------------------------------------------------------

CUSIP No. 42328V801                   13G                      Page 2 of 5 Pages


--------------------------------------------------------------------------------
     1.   Names of Reporting Persons.
          I.R.S. Identification Nos. of above persons (entities only)

          Columbus Capital Management, LLC
          94-3262667
--------------------------------------------------------------------------------
     2.   Check the Appropriate Box If a Member of a Group
          (See Instructions)
          (a)  |_|
          (b)  |_|
--------------------------------------------------------------------------------
     3.   SEC Use Only

--------------------------------------------------------------------------------
     4.   Citizenship or Place of Organization

          California, USA
--------------------------------------------------------------------------------
                   5.   SOLE VOTING POWER

                        54,504
                   -------------------------------------------------------------
                   6.   SHARED VOTING POWER
   NUMBER OF
     SHARES             0
  BENEFICIALLY     -------------------------------------------------------------
 OWNED BY EACH     7.   SOLE DISPOSITIVE POWER
   REPORTING
  PERSON WITH           54,504
                   -------------------------------------------------------------
                   8.   SHARED DISPOSITIVE POWER

                        0
--------------------------------------------------------------------------------
     9.   Aggregate Amount Beneficially Owned by Each Reporting Person

          54,504
--------------------------------------------------------------------------------
     10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares
          (See Instructions)  |_|
--------------------------------------------------------------------------------
     11.  Percent of Class Represented by Amount in Row (9)

          9.6%
--------------------------------------------------------------------------------
     12.  Type of Reporting Person (See Instructions)

          IA
--------------------------------------------------------------------------------








--------------------------------------------------------------------------------

CUSIP No. 42328V801                   13G                      Page 3 of 5 Pages


Item 1.

     (a) Name of Issuer:
         Helius Medical Technologies, Inc.

     (b) Address of Issuer's Principal Executive Offices:
         642 Newtown Yardley Road, Suite 100, Newtown, PA 18940

Item 2.

     (a) Name of Person Filing:
         Columbus Capital Management, LLC

     (b) Address of the Principal Office or, if none, residence:
         301 E. Strawberry Drive, Mill Valley, CA 94941

     (c) Citizenship:
         California, USA

     (d) Title of Class of Securities:
         Common Stock

     (e) CUSIP Number:
         42328V801

Item 3.  If this statement is filed pursuant to SS.240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:

     (a) |_| Broker or dealer registered under section 15 of the Act
             (15 U.S.C. 78o).

     (b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     (c) |_| Insurance company as defined in section 3(a)(19) of the Act
             (15 U.S.C. 78c).

     (d) |_| Investment company registered under section 8 of the Investment
             Company Act of 1940 (15 U.S.C 80a-8).

     (e) | | An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);

     (f) |_| An employee benefit plan or endowment fund in accordance with
             S.240.13d-1(b)(1)(ii)(F);

     (g) |_| A parent holding company or control person in accordance with
             S. 240.13d-1(b)(1)(ii)(G);

     (h) |_| A savings associations as defined in Section 3(b) of the Federal
             Deposit Insurance Act (12 U.S.C. 1813);

     (i) |_| A church plan that is excluded from the definition of an investment
             company under section 3(c)(14) of the Investment Company Act of
             1940 (15 U.S.C. 80a-3);

     (j) |_| Group, in accordance with S.240.13d-1(b)(1)(ii)(J).





--------------------------------------------------------------------------------

CUSIP No. 42328V801                   13G                      Page 4 of 5 Pages

Item 4.  Ownership

Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.


     (a)  Amount beneficially owned:  54,504

     (b)  Percent of class:  9.6%

     (c)  Number of shares as to which the person has:

             (i) Sole power to vote or to direct the vote:  54,504

            (ii) Shared power to vote or to direct the vote:  0

           (iii) Sole power to dispose or to direct the disposition
                 of:  54,504

          (iiii) Shared power to dispose or to direct the disposition
                 of:  0

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following |_|.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.

Item 8. Identification and Classification of Members of the Group

Item 9. Notice of Dissolution of Group

Item 10. Certification

     (a)  The following certification shall be included if the statement is
          filed pursuant to S.240.13d-1(b):

          By signing below I certify that, to the best of my knowledge and
          belief, the securities referred to above were acquired and are held in
          the ordinary course of business and were not acquired and are not held
          for the purpose of or with the effect of changing or influencing the
          control of the issuer of the securities and were not acquired and are
          not held in connection with or as a participant in any transaction
          having that purpose or effect.






--------------------------------------------------------------------------------

CUSIP No. 42328V801                   13G                      Page 5 of 5 Pages


     (b)  The following certification shall be included if the statement is
          filed pursuant to S.240.13d-1(c):

          By signing below I certify that, to the best of my knowledge and
          belief, the securities referred to above were not acquired and are not
          held for the purpose of or with the effect of changing or influencing
          the control of the issuer of the securities and were not acquired and
          are not held in connection with or as a participant in any transaction
          having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.



                                                     10/31/2023
                                    -------------------------------------------
                                                        Date


                                                 /s/ David S. Proskin
                                    -------------------------------------------
                                                     Signature


                                       David S. Proskin, Chief Financial Officer
                                    -------------------------------------------
                                                     Name/Title